Lenz, D.* ; Schlieben, L.D. ; Staufner, C.* & Prokisch, H. Response to "the race against time in genetic testing for PALF". Hepatology 81, E106-E107 (2025)
Goldberg, D.T.* et al. Novel proteomic signatures may indicate MRI-assessed intrahepatic fat state and changes; the DIRECT PLUS clinical trial. Hepatology 81, 198-211 (2024)
De Angelis Rigotti, F.* et al. Semaphorin 3C exacerbates liver fibrosis. Hepatology 78, 1092-1105 (2023)
Lenz, D.* et al. Genetic landscape of pediatric acute liver failure of indeterminate origin. Hepatology 79, 1075-1087 (2023)
Subramanian, P.* et al. The RNA binding protein HuR is a gatekeeper of liver homeostasis. Hepatology 75, 881-897 (2022)
Barahona Ponce, C.* et al. Gallstones, body mass index, C-reactive protein and gallbladder cancer—Mendelian randomization analysis of chilean and European genotype data. Hepatology 73, 1783-1796 (2021)
Brägelmann, J.* et al. Epigenome-wide analysis of methylation changes in the sequence of gallstone disease, dysplasia, and gallbladder cancer. Hepatology 73, 2293-2310 (2021)
Riedl, T.* et al. HIF1α-mediated RelB/APOBEC3B downregulation allows Hepatitis B Virus persistence. Hepatology 74, 1766-1781 (2021)
Kosinska, A. ; Kallin, A.* ; Protzer, U. & Knolle, P.A.* Overcoming liver tolerance to clear persistent HBV infection. Hepatology 68, 334A-334A (2018)
Manske, K.* et al. Outcome of antiviral immunity in the liver is shaped by the level of antigen expressed in infected hepatocytes. Hepatology 68, 2089-2105 (2018)
Michler, T. et al. Suppression of hepatitis B virus antigens by RNA interference enables therapeutic vaccination to achieve immune control in high-titer virus carriers. Hepatology 68, 49A-50A (2018)
von Loeffelholz, C.* & Birkenfeld, A.L. Reply. Hepatology 67, 452-453 (2018)
von Loeffelholz, C.* et al. The human longevity gene homolog INDY and interleukin-6 interact in hepatic lipid metabolism. Hepatology 66, 616-630 (2017)
Zhang, W.* et al. PRMT5 restricts hepatitis B virus replication via epigenetic repression of cccDNA transcription and interference with pgRNA encapsidation. Hepatology 66, 398-415 (2017)
Koppe, C.* et al. IκB kinaseα/β control biliary homeostasis and hepatocarcinogenesis in mice by phosphorylating the cell-death mediator receptor-interacting protein kinase 1. Hepatology 64, 1217-1231 (2016)
Koppe, C.* et al. A new molecular interaction between IKK alpha/beta and RIPK1 regulates biliary homeostasis and hepatocarcinogenesis. Hepatology 63, 1, 257A-258A (2016)
Li, Y.* et al. IFN-alpha-mediated Base Excision Repair Pathway Correlates with Antiviral Response Against Hepatitis B Virus Infection. Hepatology 63, 1, 921A-921A (2016)
Matter, M.S.* et al. Oncogenic driver genes and the inflammatory microenvironment dictate liver tumor phenotype. Hepatology 63, 1888-1899 (2016)
Sunami, Y.* et al. Canonical NF-κB signaling in hepatocytes acts as a tumor-suppressor in HBV surface antigen-driven HCC by controlling the UPR. Hepatology 63, 1592-1607 (2016)
Sunami, Y.* et al. Canonical NF-kappa B signaling in hepatocytes acts as a tumor-suppressor in hepatitis B virus surface antigen-driven hepatocellular carcinoma by controlling the unfolded protein response. Hepatology 63, 1, 233A-233A (2016)
Thomsen, M.K.* et al. Lack of immunological DNA sensing in hepatocytes facilitates hepatitis B virus infection. Hepatology 64, 746-759 (2016)
Endig, J.* et al. CD8+ T-cells drive liver injury and hepatocellular carcinoma in chronic liver disease. Hepatology 62, 1244A (2015)
Li, Y.* et al. IFN-α-mediated base excision repair pathway correlates with antiviral response against Hepatitis B Virus infection. Hepatology 62, 1030A (2015)
Seubert, B.* et al. TIMP-1 creates a pre-metastatic niche in the liver through SDF-1/CXCR4-dependent neutrophil recruitment in mice. Hepatology 61, 238-248 (2015)
Hösel, M.* et al. Hepatitis B virus infection enhances susceptibility towards adeno-associated viral vector transduction in vitro and in vivo. Hepatology 59, 2110-2120 (2014)
Ellinghaus, D.* et al. Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4. Hepatology 58, 1074-1083 (2013)
Jeliazkova, P.* et al. Canonical notch2 signaling determines biliary cell fates of embryonic hepatoblasts and adult hepatocytes independent of Hes1. Hepatology 57, 2469-2479 (2013)
Sprinzl, M.F. et al. Sorafenib perpetuates cellular anti-cancer effector functions by modulating the cross talk between macrophages and natural killer cells. Hepatology 57, 2358-2368 (2013)
Xia, Y. et al. Interferons induce degradation of HBV CccDNA. Hepatology 58, 274A-275A (2013)
Hösel, M.* et al. Toll-like receptor 2-mediated innate immune response in human nonparenchymal liver cells toward adeno-associated viral vectors. Hepatology 55, 287-297 (2012)
Stross, L. et al. Foxp3+ regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in mice. Hepatology 56, 873-883 (2012)
Stabenow, D.* et al. Bioluminescence imaging allows measuring CD8 T cell function in the liver. Hepatology 51, 1430-1437 (2010)
Haring, R.* et al. Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels. Hepatology 50, 1403-1411 (2009)
Hösel, M.* et al. Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection. Hepatology 50, 1773-1782 (2009)
Xing, X.* et al. Hematopoietically expressed homeobox is a target gene of farnesoid X receptor in chenodeoxycholic acid-induced liver hypertrophy. Hepatology 49, 979-988 (2009)
Geisler, F.* et al. Liver-specific inactivation of Notch2, but not Notch1, compromises intrahepatic bile duct development in mice. Hepatology 48, 607-616 (2008)
Rollier, C.S.* et al. Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity. Hepatology 45, 602-613 (2007)